AMPH R&D Expenses
Amphastar Pharmaceuticals Inc · R&D Expenses
AMPH R&D Expenses
Latest reported$22.16Mperiod ending
AMPH Quarterly R&D Expenses ($8.74M → $22.16M)
Quarterly R&D Expenses
High-resolution chart · PNG
AMPH r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 22,164,000 | |
| 26,737,000 | |
| 23,314,000 | |
| 22,354,000 | |
| 20,080,000 | |
| 20,096,000 | |
| 18,142,000 | |
| 21,077,000 | |
| 17,652,000 | |
| 14,233,000 | |
| 20,419,000 | |
| 16,664,000 | |
| 16,843,000 | |
| 19,815,000 | |
| 17,236,000 | |
| 18,514,000 | |
| 22,798,000 | |
| 16,223,000 | |
| 17,286,000 | |
| 10,759,000 | |
| 18,122,000 | |
| 14,765,000 | |
| 18,133,000 | |
| 17,644,000 | |
| 16,149,000 | |
| 15,303,000 | |
| 19,644,000 | |
| 18,606,000 | |
| 15,996,000 | |
| 14,607,000 | |
| 16,734,000 | |
| 11,340,000 | |
| 15,468,000 | |
| 14,260,000 | |
| 11,393,000 | |
| 10,040,000 | |
| 10,732,000 | |
| 11,250,000 | |
| 12,277,000 | |
| 9,723,000 | |
| 10,480,000 | |
| 8,388,000 | |
| 8,654,000 | |
| 11,117,000 | |
| 10,726,000 | |
| 6,568,000 | |
| 7,639,000 | |
| 8,585,000 | |
| 5,994,000 | |
| 6,209,000 | |
| 7,283,000 | |
| 9,041,000 | |
| 7,791,000 | |
| 8,904,000 | |
| 8,738,000 |